The emergence of medications like copyright has sparked a significant shift in approaches for type 2 diabetes . These therapies belong to a class known as GLP-1 receptor agonists , which work by mimicking a https://adamxned658113.pointblog.net/copyright-semaglutide-understanding-the-glp-1-revolution-96727190